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Purpose: The usefulness of transcranial Doppler monitoring in identifying emboli n the 
arterial circulation has been established. We attempted toextend this technique to identify 
embolism in the venous circulation and to note any changes in embolism rate with 
anticoagulation. 
Methods: From March to July 1993, 218 patients were evaluated by duplex scan for deep 
venous thrombosis. 
Results: Sixty patients had positive study results; 26 scans (43%) demonstrated mbolism. 
In five patients (19%) the emboli were also seen on a B-mode image, enabling us to 
estimate mbolus ize, which ranged from 200 to 5000 gm. Embolus counts varied from 
5 to 800 per minute. Deep venous thrombosis was located in the iliofemoral vein in 2 
patients, superficial femoral/profunda vein in 8, saphenofemoral junction in 1, popliteal 
vein in 1, and the calf in 10. Concomitantly, studies of 158 patients were negative for deep 
venous thrombosis; embolism was detected in 4 patients (3%) in this group. In patients 
taking heparin, the embolus count decreased 50% or more within 24 hours, and all 
embolism was abolished within 72 hours. Two patients died of pulmonary embolus. 
Conclusion: Patients with duplex scans that are positive for deep venous thrombosis have 
a high incidence of ongoing embolism. Heparin appears effective in eliminating the 
microemboli detected. The relationship among microembolism, deep venous thrombosis, 
and clinically significant pulmonary embolism remains to be elucidated. (J VAsc SURG 
1996;511-6.) 
The use of Doppler ultrasound to identify intra- 
vascular embolism in the clinical setting was first 
reported after routine use of  intraoperative monitor- 
ing with transcranial Doppler during carotid endar- 
terectomy.~ Spectral signatures thought o represent 
emboli in the velocity waveform of the middle 
cerebral artery were identified. The ability to distin- 
guish spectral signatures of  air from particulate 
emboli was subsequently reported in an in vivo 
model. 2 With the technique of  intimal injury and 
extrinsically applied stenosis described by Folts et al. "~, 
the method has now been used to detect platelet 
emboli generated in the intact arterial system of 
domestic swine. 4 Validation of the spectral criteria 
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for particulate mboli in in vivo 5,~ and in vitro 7'~ 
models has been reported by several authors. Clini- 
cally, transcranial Doppler monitoring has been used 
to identify patients with both symptomatic and 
asymptomatic carotid lesions who were thought o 
have active embolism to the middle cerebral artery 
distribution. ~ 0
We hypothesized that Doppler ultrasound could 
also be used to detect embolism in the venous 
circulation, specifically in patients with demonstrated 
deep vein thrombosis (DVT), and to further define a 
relationship between duplex-detected microembo- 
lism and clinical pulmonary embolism. 
PATIENTS AND METHODS 
We prospectively evaluated all 218 patients re- 
ferred to the vascular laboratory for diagnosis of 
DVT between March and July 1993. Each patient 
underwent standard venous duplex examination. 
Studies were performed with an Ultramark 9 duplex 
scanner (ATL; Bothell, Wash.). 
With the patient supine, Doppler signals were 
obtained at the common femoral vein at the groin, 
the superficial femoral vein at midthigh, the popliteal 
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Fig. 1. Transverse section on B-mode image taken at level at which greater saphenous vein 
enters common femoral vein. Thrombus is seen occupying common femoral vein and extending 
into the greater saphenous vein. 
vein behind the knee, the posterior tibial vein at the 
ankle, and the greater saphenous vein in the thigh. 
Audible flow characteristics were evaluated for spon- 
taneity and phasicity, and by augmentation. 
Thrombi also were sought with B-mode or 2D 
imaging (Fig. 1). Standard sampling sites for em- 
bolus detection were the popliteal vein and the 
common femoral vein; however, in most patients 
the B-mode image gave no evidence of DVT at 
those sites. In general, the sampling site was always 
upstream and further than one scan field from any 
B-mode thrombus. 
Accumulated experience in listening to arterial 
embolic Doppler signals enabled recognition of 
embolic spectral signatures in the venous circulation. 
In general, they adhere to the criteria for arterial 
emboli originally defined by Spencer et al. 1 in 1990, 
which we have revised as follows. 
These basic features are always present when the 
signals are recorded optimally. 
1. Short duration, usually < 0.3 second. 
2. Duration depends on time of passage through the 
Doppler sample volume. 
3. Amplitude is greater than the blood flow signal 
depending on size, character, embolus-to-blood 
ratio, and the ultrasonic arrier frequency. 
4. Unidirectional within the spectrum on bidirec- 
tional Doppler equipment. 
5. Sound to the ear as snaps, tonal chirps, or moans 
depending on velocity. 
When these features are all present, the result is 
called a "Doppler embolic signal" (Fig. 2). 
Data were not reported in a strictly blinded 
fashion. The senior author (SCN) in most cases 
reviewed the tapes for embolic spectra without 
knowledge of previous diagnosis of thrombus on the 
B-mode image of the duplex scan. He was, however, 
clinically involved with several patients. 
We have improved both the ability to detect 
emboli and the clarity of emboli signatures by using 
low gain settings (to reduce background flow signal 
and improve discrimination of embolic signatures), 
low-frequency probes (lower ultrasonic arrier fre- 
quencies result in improved detection rate), and 
continuous-wave Doppler imaging (Fig. 3). These 
features are, in part, predictable from theoretic 
considerations (Rayleigh's law of scattering). 9 
We also attempted to visualize emboli with 
real-time B-mode imaging. Emboli were difficult to 
image with this method unless they were trapped 
behind a valve cusp when they had low velocity. 
When visualization was successful, slowly moving 
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Fig. 2. Split-screen display with B mode in left panel and Doppler spectrum on right. In left 
panel sample volume is placed in common femoral vein just above bifurcation. Doppler 
spectrum isdisplayed at right, where several embolic signatures represent increased backscatter 
energy of ultrasound beam from emboli. Their amplitude is greater than blood-flow signal 
depending on size, character, embolus-to-blood rati , and ultrasonic carrier frequency. Highly 
variable amplitude is noted, suggesting variation in sizeof emboli. 
emboli were recorded on the B-mode image, which 
was then frozen; an estimate ofembolus ize was then 
made with a calibrated software package (Fig. 4). 
In patients who underwent sequential studies and 
in whom heparin administration was begun after the 
initial study, we recorded changes in rates of embo- 
lism (counts/minute). 
RESULTS 
Of 218 patients scanned for venous thrombosis, 
DVT was diagnosed by standard criteria in 60. 
Twenty-six (43%) demonstrated embolism in the 
Doppler spectrum. Embolism was observed in the 
absence of thrombosis in four patients. In five 
patients (19%), emboli were also seen on the 
real-time B-mode image. 
Of 22 patients with DVT and embolism, eight 
(36%) were referred to the vascular laboratory for 
shortness of breath. Arterial blood gasses were avail- 
able in 18 (82%). All had pO 2 values < 70 mm Hg 
when equilibrated to room air. Hypocarbia was more 
variable, with pCO2 values ranging from 27 to 48 
mm Hg. The higher values are presumed to result 
from hypoventilation related to injury. Sixteen pa- 
tients had been admitted with trauma; five patients in 
this subgroup had an associated diagnosis of puhno- 
nary contusion. 
Patients were classified by the location of DVT 
(Table I). The majority, in 10 patients, were in the 
calf: In two of these patients, orthopedic asts and 
hardware made complete valuation difficult. 
In the five patients in whom emboli were seen on 
B-mode images, the size, as measured on the screen 
by the sofiware package, ranged from 200 to 5000 
~m. Patients were observed over time, which enabled 
embohis counts per minute to be calculated. These 
counts ranged from as few as 5 per minute to as many 
as 800 per minute. No relationship between the size 
of emboli and the counts was observed. 
Lung scans were available in nine patients. Scans 
were reported as having high probability for pulmo- 
nary embolus in two, intermediate probability in 
two, and low probability in five. Two patients ubse- 
quently died of pulmonary embolus. Their throm- 
boses were located in the iliofemoral and superficial 
femoral veins. Their embolus counts were 10 and 300 
per minute. 
Fourteen patients were given a full dose of 
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Table I. Location of DVT 
No. of 
Location patients 
Iliofemoral 2 
SFV/profunda 8 
Saphenofemoral junction 1 
Popfiteal 1 
Calf i0 
Embolism without observed thrombosis 4 
Total 26 
SVF: superficial femoral vein. 
Fig. 3. Embolic signature detection is highly dependent 
on instrumentation. Superior signal clarity is demonstrated 
by use of 2-MHz continuous wave probe (bottom) as 
opposed to 2-MHz pulsed probe (top). 
intravenous heparin after their initial scan and all 
received follow-up studies. Greenfield filters were 
placed in two patients. Some clinicians believed that 
the significance of venous microembolism was not 
established and did not justify subjecting the patient 
to full heparinization. Several elected to institute sub- 
cutaneous heparin. In patients fully heparinized after 
their initial scan, within 24 hours the mbolus count 
was diminished to < 50% of the count from the 
original minute. All patients given heparin were free 
of emboli within 72 hours. Although it is possible 
that the process of microembolism ay be self- 
limiting, it appeared likely that heparin had a direct 
beneficial effect on the rate and extent of embolism. 
DVT was not diagnosed in 158 patients. Only 
four of these (3%) had embolism; in two the presence 
of orthopedic asts and hardware made complete 
evaluation impossible. It is possible that undetected 
soleal sinus thrombosis was present. It therefore 
appears that in the absence of venous thrombosis, 
microembolism is exceedingly rare. 
DISCUSSION 
The association between DVT in the legs and 
pulmonary embolus (PE) was first described by 
Virchow in 1846. In his seminal book Die Cellular 
Pathologie, which was translated into English in 
1860~ 11 he also described the three predisposing 
causes of thrombosis: changes in the vessel wall, the 
blood flow, and the blood. Despite this insightful 
description of the pathophysiology, venous throm- 
boembolism remains an enigmatic entity. 
In 1960, after meticulously dissecting the pulmo- 
nary arteries in a large number of trauma victims, 
Sevitt and Gallagher 12 concluded that pulmonary 
embolism was the most common single cause of 
death in older injured patients. The most likely source 
of these emboli was believed to be thrombus formed 
in the deep veins of the leg. In a 1969 publication the 
National Academy of Science stated, "Thromboem- 
bolic disease is a leading cause of morbidity and 
mortality in the United States, but its importance as 
a national medical problem is inadequately appreci- 
ated. "~s In a population-based stimate of the hos- 
pital incidence and case mortality rates of DVT and 
pulmonary embolism, Anderson et al.14 reported an 
average annual incidence of DVT of 48 per 100,000 
and an incidence of pulmonary embolism, with or 
without DVT, of 23 per 100,000. Extrapolation of 
these data suggested that approximately 170,000 
patients had a recognized initial episode of venous 
thromboembolism treated in short-stay hospitals in 
the United States each year; there were an additional 
90,000 cases of recurrent disease. Elsewhere, it has 
been estimated that venous thromboembolism causes 
more than 100,000 deaths annually in the United 
States and may contribute to death in another 
100,000 people? s Even these figures are thought by 
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Fig. 4. Longitudinal section at confluence of profunda, superficial femoral, nd common 
femoral veins. Valve cusp is clearly seen inferiorly at termination f superficial femoral vein. 
Another cusp is located superiorly (but not well seen in the plane) and traps emboli exiting 
superficial femoral vein. They randomly float back into centerstream with minimal velocity and 
are then seen on B-mode image (arrow). 
many to be underestimates. The problem is that DVT 
and PE manifest few specific symptoms. ~6 Pulmonary 
embolism is aptly referred to as the silent killer. 
Clearly this major health problem is underdiagnosed. 
Much remains to be understood about its patho- 
physiology.. 
Until now, no diagnostic method has enabled 
direct demonstration f the phenomenon ofongoing 
venous system embolism or the effcct of instituting 
anticoagulant therapy. Clinical observation usually 
supports the occurrence of a single embolic event hat 
results in acutc pulmonary insufficiency. It may be, 
however, that the process is analogous to that 
observed in the cerebrovascular ci culation, in which 
patients may have a single sevcrc event (stroke) or a 
more slowly evolving clinical picture that is initially 
asymptomatic with a gradual onset (multi-infarct 
dementia). In any event, it seems reasonable to 
assume that because of fibrinolysis and other mecha- 
nisms the pulmonary vascular bed is capable of 
sustaining a certain level of thromboembolism with- 
out apparent clinical decompensation. Thus the onset 
of the disease is insidious. 
Thc data from this study suggest that microcm- 
bolism is frequent, occurs on a continuous basis, and 
is often well tolerated. The cumulative ffect, how- 
ever, may present as an acute episode. Patients 
initially will demonstrate f w or no symptoms during 
a period of ongoing embolism before they finally 
reach a point of decompensation. It has been 
estimated that a clinically detectable hemodynamic 
effect occurs when 50% of the pulmonary arterial tree 
is involved. 
The use of Doppler ultrasound should improve 
the diagnosis and management of pulmonary embo- 
lism in several areas. 
1. Differential diagnosis of pulmonary insufficiency. 
In several patients in this series, "acute exacerba- 
tion of chronic obstructive pulmonary disease" or 
pneumonia were diagnosed. 
2. Early detection of the embolic process. If un- 
treated, sustained acute minor pulmonary embo- 
lism can progress to subacute massive pulmonary 
embolism or chronic thromboembolic pulmonary 
hypertension. The prognosis for the latter is poor 
and treatment is generally ineffective. 
3. "Low-probability lung scan." Often this result 
reassures the clinician that a serious problem has 
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been ruled out and that further evaluation is not 
required. This may be the patient group in which 
the cause of the ventilation perfusion mismatch 
should be pursued. 
4. Finally, this method can be used to directly assess 
the efficacy of anticoagulation regimens. 17 
Although microembolism is apparently common 
in the presence of demonstrated DVT and appears 
sensitive to heparin therapy, more longitudinal data 
will be required to elucidate the significance of 
embolism rate and embolus ize and their relation- 
ship to clinical pulmonary embolism. 
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